Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Doug Levinson
AddedMar 31, 2024
UpdatedMay 31, 2026
Doug Levinson

Doug Levinson

Co-Founder & CEO, Fount Bio

CrunchbaseLinkedIn

Doug Levinson's Career

Fount Bio
Fount Bio

Cambridge, MA, US

Co-Founder & CEO· C-Suite · Management
YourBio Health
YourBio Health

Cambridge, MA, US

Founder
Cytrellis Biosystems
Cytrellis Biosystems

Woburn, MA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Doug Levinson's Career

Fount Bio
Fount Bio
Series A$8.2M92018Cambridge, MA, US
Co-Founder & CEO· C-Suite · Management

Leadership at Fount Bio

Justin BurnsJustin BurnsBoard Member
Anthony AiudiAnthony AiudiBoard Member
Samir MitragotriSamir MitragotriCo-Founder
YourBio Health
YourBio Health
Series B$98.2M332008Cambridge, MA, US
Founder

Leadership at YourBio Health

Harry WilcoxHarry WilcoxBoard Member

Similar to YourBio Health

Weavr HealthWeavr HealthCambridge, MA, USMedical Devicesest. 2005Weavr HealthCambridge, MA, US · est. 2005

Weavr Health: Creating reliable, easy-to-use blood collection devices for accessible health care.

Series B · $22.7M30
BioFluidicaBioFluidicaSan Diego, CA, USDiagnostic Platformsest. 2006BioFluidicaSan Diego, CA, US · est. 2006

BioFluidica, a San Diego-based biotech firm, develops diagnostic platforms for disease management, specializing in circulating tumor cells.

Series B · $19.2M19
Babson DiagnosticsBabson DiagnosticsAustin, TX, USBlood Testingest. 2017Babson DiagnosticsAustin, TX, US · est. 2017

Babson Diagnostics: Making diagnostic blood testing convenient and accessible with innovative medical technology.

Series B · $44.7M48
TassoTassoSeattle, WA, USMedical Devicesest. 2012TassoSeattle, WA, US · est. 2012

Tasso, a Seattle-based company, revolutionizes blood diagnostics with user-friendly home sampling devices.

Series B · $135.4M75
Cytrellis Biosystems
Cytrellis Biosystems
Series C$86.1M1162012Woburn, MA, US
Founder

Leadership at Cytrellis Biosystems

John McDonoughJohn McDonoughBoard Member
Keith CrandellKeith CrandellBoard Member
Frederick BeddingfieldFrederick BeddingfieldBoard Member
Michael PetersonMichael PetersonBoard Member
Amit MunshiAmit MunshiBoard Member
R Jason RicheyR Jason RicheyCEO

Similar to Cytrellis Biosystems

Cellutions BiosystemsCellutions BiosystemsDuluth, GA, USMedical Devicesest. 2002Cellutions BiosystemsDuluth, GA, US · est. 2002

Cellutions develops proprietary medical devices for minimally invasive cellulite treatments.

Pre-Seed · $22.4M375
Syntr Health TechnologiesSyntr Health TechnologiesIrvine, CA, USMedical Devicesest. 2016Syntr Health TechnologiesIrvine, CA, US · est. 2016

Syntr Health Technologies: Innovating body contouring devices, founded by biomedical experts.

Series A · $2.2M8
SeaStar MedicalSeaStar MedicalAnn Arbor, MI, USMedical Devicesest. 2007SeaStar MedicalAnn Arbor, MI, US · est. 2007

CytoPherx Inc. offers proprietary medical devices for treating inflammation-based diseases.

Series C · $50.2M5
jCytejCyteNewport Beach, CA, USCell Therapyest. 2012jCyteNewport Beach, CA, US · est. 2012

US-based jCyte pioneers in progenitor cell technology for retinal diseases, offering non-surgical jCell treatment.

Series A · $3.9M11

Doug Levinson's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Doug Levinson

Andrew HerrAndrew HerrFounder · FountVolker JacobsVolker JacobsCo-Founder · Fount GlobalDon DavidsonDon DavidsonCo-Founder · Creative BioTherapeuticsHoward UrnovitzHoward UrnovitzFounder · Calypte BiomedicalHanson GiffordHanson GiffordCo-Founder · Nexis VisionFrank TangFrank TangFounder · FountainVest Partners